Chemical Structure : Ruxolitinib
CAS No.: 941678-49-5
Catalog No.: PC-45872Not For Human Use, Lab Use Only.
Ruxolitinib (INCB-018424) is a potent, selective, orally active JAK1/JAK2 inhibitor with IC50 of 3.3/2.8 nM, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
50 mg | $98 | In stock | |
100 mg | $128 | In stock | |
200 mg | $188 | In stock | |
1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Ruxolitinib (INCB-018424) is a potent, selective, orally active JAK1/JAK2 inhibitor with IC50 of 3.3/2.8 nM, respectively.
Ruxolitinib (INCB-018424) displays modest selectivity against Tyk2 (6-fold) and marked selectivity (>130-fold) against JAK3.
Ruxolitinib (INCB-018424) inhibits IL-6 signaling (IC50=281 nM), and proliferation of JAK2V617F(+) Ba/F3 cells (IC50=127 nM).
Ruxolitinib (INCB-018424) suppresses erythroid progenitor colony formation from JAK2V617F(+) polycythemia vera patients (IC50=67 nM) in primary cultures.
Ruxolitinib (INCB-018424) markedly reduces level of inflammatory cytokines, and preferentially eliminates neoplastic cells in a mouse model of JAK2V617F(+) MPN.
M.Wt | 306.365 | |
Formula | C17H18N6 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: ≥ 36 mg/mL; H2O: < 0.1 mg/mL |
|
Chemical Name/SMILES |
1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)- |
1. Quintás-Cardama A, et al. Blood. 2010 Apr 15;115(15):3109-17.
2. Fridman JS, et al. J Immunol. 2010 May 1;184(9):5298-307.
3. Verstovsek S, et al. N Engl J Med. 2010 Sep 16;363(12):1117-27.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright